Dianthus Therapeutics
DNTH
DNTH
50 hedge funds and large institutions have $23.4M invested in Dianthus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
4% less funds holding
Funds holding: 52 → 50 (-2)
Holders
50
Holding in Top 10
1
Calls
$12K
Puts
$9K
Top Buyers
1 | +$4.81M | |
2 | +$3.62M | |
3 | +$1.75M | |
4 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$1.14M |
5 |
TG
TCW Group
Los Angeles,
California
|
+$596K |
Top Sellers
1 | -$2.67M | |
2 | -$1.19M | |
3 | -$914K | |
4 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$343K |
5 |
IHAM
Integral Health Asset Management
New York
|
-$164K |